How did Procter & Gamble's net sales perform in the third quarter?

For the three months ended March 31, 2024, Procter & Gamble reported net sales of $20.2 billion, a 1% increase compared to the prior year period. This growth was primarily driven by a 3% increase in pricing, which offset a 2% unfavorable foreign exchange impact. Unit volume and mix had a neutral impact. Organic sales, excluding foreign exchange, acquisitions, and divestitures, increased by 3%.

What was the impact of the Gillette intangible asset impairment on the company's financial results?

During the three months ended December 31, 2023 (recognized within the nine-month reporting period), Procter & Gamble recorded a non-cash impairment charge of $1.3 billion before tax ($1.0 billion after tax) on the Gillette indefinite-lived intangible asset. This charge negatively impacted the nine-month net earnings and diluted EPS. Management considers this an irregular item and excludes it when calculating Core EPS.

How has the company's gross margin trended?

Procter & Gamble demonstrated strong gross margin performance. For the three months ended March 31, 2024, gross margin increased 300 basis points to 51.2% of net sales. This improvement was attributed to manufacturing productivity savings (260 basis points), lower commodity costs (130 basis points), and higher pricing (130 basis points), partially offset by unfavorable product mix and foreign exchange.

What is the outlook for cash flow and shareholder returns?

The company generated $14.1 billion in operating cash flow for the nine months ended March 31, 2024. Adjusted free cash flow was $12.0 billion, with an adjusted free cash flow productivity of 93%. P&G continues to return capital to shareholders, repurchasing approximately $6.3 billion in shares during the quarter and intending to reduce outstanding shares by $5 to $6 billion in fiscal year 2024.

PG 10-Q Quarterly Report Q3 FY2024 — Revenue, Net Income, EPS

Summary

Procter & Gamble Co. (PG) reported solid financial results for the third quarter and nine months ended March 31, 2024. Net sales saw a modest increase of 1% for the quarter and 3% for the nine-month period, driven by strategic pricing initiatives that offset some foreign exchange headwinds and flat unit volumes. The company demonstrated strong operational execution, evidenced by significant improvements in gross margin, primarily due to manufacturing productivity savings and lower commodity costs. Profitability showed a healthy upward trend, with net earnings attributable to Procter & Gamble increasing by 11% for the quarter and 4% for the nine-month period. Diluted Earnings Per Share (EPS) also saw substantial growth. The company continued its commitment to returning value to shareholders through share repurchases and dividends, supported by robust operating cash flow of $14.1 billion for the nine months. A key event impacting earnings was a $1.3 billion pre-tax impairment charge on the Gillette intangible asset, which was noted as a non-recurring item impacting the nine-month results. Management highlighted the strength across several business segments, with Fabric & Home Care and Baby, Feminine & Family Care showing particularly strong earnings growth for the nine-month period. The company remains focused on productivity, pricing, and innovation to navigate the complex global economic landscape, which includes managing currency fluctuations and cost pressures. Overall, PG presented a picture of resilience and continued strategic focus on driving profitable growth.

Financial Highlights

54 data points

Beta

Revenue

$20.20B

0.5% Gross Margin

Net Income

$3.75B

0.2% Net Margin

EPS (Diluted)

$1.52

Total Assets

$119.60B

Cash & Equivalents

$6.83B

Free Cash Flow

$3.29B

Financial Statements

Beta

Revenue	$20.20B
Cost of Revenue	$9.86B
Gross Profit	$10.34B
SG&A Expenses	$5.88B
Operating Income	$4.46B
Interest Expense	$233.00M
Net Income	$3.75B
EPS (Basic)	$1.56
EPS (Diluted)	$1.52
Shares Outstanding (Basic)	2.36B
Shares Outstanding (Diluted)	2.47B

Key Highlights

1Net sales for the third quarter increased 1% to $20.2 billion, with organic sales up 3%, driven by pricing.
2Net earnings attributable to Procter & Gamble rose 11% to $3.75 billion for the quarter, and Diluted EPS increased 11% to $1.52.
3Gross margin improved significantly by 300 basis points to 51.2% in the quarter, benefiting from manufacturing productivity and lower commodity costs.
4Operating cash flow for the nine months was strong at $14.1 billion, contributing to an adjusted free cash flow of $12.0 billion.
5A $1.3 billion pre-tax impairment charge on the Gillette intangible asset negatively impacted nine-month earnings.
6Key segments like Fabric & Home Care and Baby, Feminine & Family Care showed robust net earnings growth of 11% and 8% respectively for the quarter.
7The company repurchased $6.3 billion in shares during the first three months of the calendar year, signaling a commitment to shareholder returns.

PROCTER & GAMBLE Co Quarterly Report for Q3 Ended Mar 31, 2024

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions